OTC healthcare in Switzerland
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 1999-2004
2.11 Life Expectancy
Table 2 Life Expectancy at Birth 1999-2004
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
3.2 Switches
Summary 1 OTC Healthcare Switches 2003-2005
3.3 Competitive Environment
Table 5 OTC Healthcare Company Shares 2001-2004
Table 6 OTC Healthcare Brand Shares 2001-2004
3.4 Leading Company Profiles – Bioforce AG
Summary 2 Bioforce AG Operational Indicators 2004
3.5 Leading Company Profiles – Galenica Holding AG
Summary 3 Galenica Operational Indicators 2004
3.6 Leading Company Profiles – Novartis Consumer Health Schweiz AG
Summary 4 Novartis Consumer Health Schweiz AG Operational Indicators 2004
3.7 Leading Company Profiles – Spirig Pharma AG
Summary 5 Spirig Pharma AG Operational Indicators 2004
3.8 Retail Distribution
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
3.9 Retailer Activity and Private Label Trends
Table 9 Penetration of Private Label by Sector 2001-2004
3.10 Forecast Market Performance
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009
4. WOUND TREATMENTS SALES
4.1 Sector Performance
Table 12 Sales of Wound Treatments by Subsector: Value 1999-2004
Table 13 Sales of Wound Treatments by Subsector: % Value Growth 1999-2004
Table 14 Wound Treatments Company Shares 2001-2004
Table 15 Wound Treatments Brand Shares 2001-2004
Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2004-2009
Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
Summary 6 Wound Treatments: New Product Launches 2004-2005
5. OTHER OTC
6. DEFINITIONS
